Northern Trust Corp Lowers Stock Position in LifeStance Health Group, Inc. $LFST

Key Points

• Northern Trust Corp reduced its stake in LifeStance Health Group by 3.8%, holding 1,531,272 shares valued at approximately $10.2 million after selling 60,504 shares.
• Several hedge funds have increased their investments in LifeStance Health Group, including Victory Capital Management, which raised its holdings by an extraordinary 2,599%.
• LifeStance Health Group's latest earnings report showed a revenue increase of 10.6% year-over-year, with Q2 earnings per share at ($0.01), exceeding estimates of ($0.03).

Northern Trust Corp cut its holdings in shares of LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 3.8% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,531,272 shares of the company's stock after selling 60,504 shares during the period. Northern Trust Corp owned 0.39% of LifeStance Health Group worth $10,198,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Parcion Private Wealth LLC purchased a new position in shares of LifeStance Health Group during the first quarter worth approximately $15,670,000. Janus Henderson Group PLC lifted its holdings in shares of LifeStance Health Group by 51.4% during the fourth quarter. Janus Henderson Group PLC now owns 59,500 shares of the company's stock worth $439,000 after purchasing an additional 20,200 shares during the period. Victory Capital Management Inc. lifted its holdings in shares of LifeStance Health Group by 2,599.0% during the first quarter. Victory Capital Management Inc. now owns 370,598 shares of the company's stock worth $2,468,000 after purchasing an additional 356,867 shares during the period. Versor Investments LP lifted its holdings in shares of LifeStance Health Group by 1,113.5% during the first quarter. Versor Investments LP now owns 216,000 shares of the company's stock worth $1,439,000 after purchasing an additional 198,200 shares during the period. Finally, Two Sigma Advisers LP acquired a new stake in shares of LifeStance Health Group during the fourth quarter worth $183,000. 85.50% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on LFST shares. UBS Group increased their price target on LifeStance Health Group from $8.50 to $9.00 and gave the stock a "buy" rating in a report on Friday, August 8th. BTIG Research started coverage on LifeStance Health Group in a report on Friday, July 25th. They set a "buy" rating and a $8.00 price target for the company. Finally, Wall Street Zen raised LifeStance Health Group from a "hold" rating to a "buy" rating in a report on Saturday, August 9th. One research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, LifeStance Health Group currently has a consensus rating of "Moderate Buy" and an average target price of $8.50.

LifeStance Health Group Price Performance

LifeStance Health Group stock opened at $5.37 on Friday. LifeStance Health Group, Inc. has a one year low of $3.74 and a one year high of $8.61. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.48 and a current ratio of 1.48. The business has a fifty day moving average of $4.77 and a two-hundred day moving average of $5.83. The company has a market cap of $2.09 billion, a P/E ratio of -107.40 and a beta of 1.17.

LifeStance Health Group (NASDAQ:LFST - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported ($0.01) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.03) by $0.02. The business had revenue of $345.31 million during the quarter, compared to the consensus estimate of $345.05 million. LifeStance Health Group had a negative return on equity of 1.11% and a negative net margin of 1.23%.The business's revenue was up 10.6% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.06) EPS. LifeStance Health Group has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, analysts predict that LifeStance Health Group, Inc. will post -0.18 earnings per share for the current fiscal year.

Insider Transactions at LifeStance Health Group

In other news, Director Darren M. Black sold 8,407,643 shares of LifeStance Health Group stock in a transaction on Monday, August 18th. The stock was sold at an average price of $5.07, for a total transaction of $42,626,750.01. Following the completion of the transaction, the director owned 33,524,715 shares of the company's stock, valued at $169,970,305.05. The trade was a 20.05% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, major shareholder Summit Partners L. P sold 8,407,643 shares of LifeStance Health Group stock in a transaction on Monday, August 18th. The stock was sold at an average price of $5.07, for a total value of $42,626,750.01. Following the transaction, the insider directly owned 33,524,715 shares of the company's stock, valued at $169,970,305.05. This trade represents a 20.05% decrease in their position. The disclosure for this sale can be found here. Insiders sold 20,407,643 shares of company stock valued at $103,466,750 in the last 90 days. 3.20% of the stock is currently owned by insiders.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.

Want to see what other hedge funds are holding LFST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.